The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Boston Scientific Corporation’s stock is up 53.1% in 2024, up 4.4% in the previous five trading days and up 72.04% in the past year. Currently, Boston Scientific Corporation’s price-earnings ratio is ...

Needham has recently reduced Boston Scientific Corporation (BSX) stock to Hold rating, as announced on October 18, 2024, according to Finviz. Earlier, on May 30, 2024, Goldman had initiated the stock ...

Credit: Sundry Photography via Shutterstock. Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations” ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...